Indication
TIL
3 clinical trials
3 products
Clinical trial
An Open, Single-armed, Phase I Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-11-07
Product
TIL therapyClinical trial
A Clinical Study on Tumor Infiltrating Lymphocytes for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-10
Clinical trial
A Study on Tumor Infiltrating Lymphocytes for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-06-30
Product
GC203 TIL